NOTE 5. DEBT
At October 1, 2010, the Company’s total debt outstanding was $727.6 million as compared to
$830.1 million at January 1, 2010. The Company’s weighted-average cost of borrowings was 6.1% and
7.7% for the three months ended October 1, 2010 and October 2, 2009, respectively, and 6.6% and
6.4% for the nine months ended October 1, 2010 and October 2, 2009, respectively.
Convertible Notes and Special Dividend
Prior to the declaration of the special dividend in the third quarter of 2010 (see Note 10.
“Stockholders’ Equity”), the Notes due 2013 were convertible, at the holders’ option, at an
initial conversion rate of 15.753 shares per $1,000 principal amount of Notes due 2013, equivalent
to a conversion price of $63.48 per share. As a result of the payment of the special dividend in
October 2010, the conversion rate and conversion price were adjusted. Beginning in October 2010,
holders of the Notes due 2013 may convert each Note into 16.727 shares, compared to 15.753 shares
before the adjustment of the Company’s common stock, for which the Company has reserved 5.0
million of its authorized shares compared to 4.7 million shares before the adjustment. The
conversion price of $63.48 was adjusted to $59.78 per share.
In periods in which the Notes due 2013 are convertible, any conversion will be settled in cash
up to the principal amount, and any excess conversion value will be delivered, at the Company’s
election in cash, common stock or a combination of cash and common stock. Based on the Company’s
stock price at the end of the third quarter of 2010, the Notes due 2013 are not currently
convertible.
In connection with the Notes due 2013 issuance in February 2007, the Company paid $88.8
million ($54.7 million net of tax) for a call option that initially covered 4.7 million shares of
its common stock, subject to customary anti-dilution adjustments. Prior to the declaration of the
special dividend during the third quarter of 2010, the purchased call option had an exercise price
$63.48. As a result of the special dividend, this price was adjusted to $59.78 per share and the
shares related to the call option were adjusted to 5.0 million shares.
Concurrently with purchasing the call option, the Company sold to the counterparty for $52.0
million a warrant to purchase 4.7 million shares of its common stock, subject to customary
anti-dilution adjustments. Prior to the declaration of the special dividend during the third
quarter of 2010, the sold warrant had an exercise price of $82.80
and may not be exercised prior to the maturity of the notes. As a result of the special
dividend, this price was adjusted to $77.98 per share and the shares related to the warrant were
adjusted to 5.0 million shares.
At the end of the third quarter of 2010, the Notes due 2033 have an aggregate principal amount
at maturity of $162.7 million and an accreted value of $78.2 million. The principal amount at
maturity of each Note due 2033 is $1,000. Holders may surrender these securities for conversion if
the sale price of the Company’s common stock for at least 20 trading days in a period of 30
consecutive trading days ending on the last trading day of the preceding fiscal quarter is more
than 120% of the accreted conversion price per share of common stock on the last day of such
preceding fiscal quarter. In periods in which the Notes due 2033 are convertible, any conversion
will be settled in cash up to the principal amount, and any excess of the accreted principal amount
will be settled in common stock. Based on the Company’s stock price at the end of the third
quarter of 2010, the Notes due 2033 are currently convertible.
The accreted conversion price per share as of any day will equal the initial principal amount
of this security plus the accrued issue discount to that day, divided by the conversion rate on
that day. Prior to the payment of the special dividend in October 2010, holders of the Notes due
2033 could convert each Note into 15.067 shares of the Company’s common stock for which the Company
had reserved 2.2 million of its authorized shares. As a result of the payment of the special
dividend in October 2010, the conversion rate was adjusted to 16.023 shares and the Company has now
reserved 2.3 million of its authorized shares.
For further information regarding the special dividend, see Note 10. “Stockholders’ Equity.”
Repurchases of Debt
During the nine months ended October 1, 2010, the Company retired $133.7 million of accreted
value of its 10% Senior Notes due 2014 (“Notes due 2014”) for $165.5 million. Available cash and
other borrowings were used to retire these notes. As a result of the retirements, the Company
recognized a pre-tax loss for the three and nine months ended October 1, 2010 of $2.8 million and
$33.3 million, respectively, inclusive of $0.2 million and $2.7 million, respectively, of debt
issuance costs that were written off and $0.3 million of fees associated with the repurchase.
During the nine months ended October 1, 2010, the Company repurchased a portion of the Notes
due 2033 for $63.0 million of which $8.4 million was accrued at the end of the third quarter.
Available cash and other borrowings were used to repurchase these notes. In connection with the
repurchases, the Company reduced the accreted value of the debt by $36.8 million, recorded a
reduction in equity of $16.8 million (reflecting the fair value of the conversion option at the
time of repurchase) and reduced deferred tax liabilities by $10.3 million. The repurchases
resulted in the recognition of a pre-tax gain for the three and nine months ended October 1, 2010
of $0.1 million and $0.9 million, respectively.
Other
Certain debt agreements entered into by the Company’s operating subsidiaries contain various
restrictions, including restrictions on payments to the Company. These restrictions have not had,
nor are expected to have, an adverse impact on the Company’s ability to meet its cash obligations.
The Company has approximately $321.8 million in available, committed, unused credit lines and, at
October 1, 2010 has drawn $75.0 million of borrowings under its $200 million accounts receivable
facility.
The Company may redeem its Notes due 2033, in whole or in part, on July 7, 2011 for cash at
the accreted value. Additionally, holders may require the Company to purchase all or a portion of
their Convertible Notes due 2033 at various prices on certain future dates beginning July 7, 2011.
The Company is required to pay the purchase price in cash. The Notes due 2033 are structurally
subordinated to the indebtedness of Anixter. Although the notes were convertible at the October 1,
2010, they are classified as long-term as the Company has the intent and ability to refinance the
accreted value under existing long-term financing agreements available at October 1, 2010.
On July 23, 2010, the Company’s primary operating subsidiary, Anixter Inc., renewed its
accounts receivable securitization program for a new 364-day period ending in July of 2011.
Specifically, the Company amended its Amended and Restated Receivables Purchase Agreement and its
Amended and Restated Receivables Sale Agreement, both dated October 3, 2002. The renewed program
carries an all-in drawn funding cost of Commercial Paper (“CP”) plus 115 basis points (previously
CP plus 150 basis points). Unused capacity fees decreased from a range of 75 to 85 basis points to
a range of 57.5 to 60 basis points. All other material terms and conditions remain unchanged.
See Note 7. “Fair Value Measurements” for information related to the fair value of outstanding
debt obligations.